Search results for " Crònica"
showing 4 items of 14 documents
Les fonts grega i francesa de la versió aragonesa de la Crònica de Morea
2016
La versió aragonesa de la Crònica de Morea o Libro de los fechos et conquistas del Principado de la Morea fou un encàrrec de Johan Ferrández d'Heredia, mestre de l'orde de Sant Joan de Jerusalem, al seu scriptorium d'Avinyó. A jutjar pels seus gal·licismes i hel·lenismes, les seues fonts són diversos textos francesos i grecs. El manuscrit aragonés resultant es desmarca així dels altres manuscrits grecs, francés i italià en nombrosos aspectes. The Aragonese version of The Chronicle of Morea or Libro de los fechos et conquistas del Principado de la Morea was ordered by Johan Ferrández d'Heredia, Grand Master of the Knights of Saint John of the Hospital, to his scriptorium in Avignon. Regardin…
Centre d'Educació Especial Auxilia. Un model d'atenció acadèmica domiciliària
2011
This article describes a pioneering experience in education - Auxilia Centre for Special Education. This centre provides continuity for the education of children affected by physical disabilities, chronic illness or psychiatric illness and who, because of their illness, are forced to stay at home for certain periods without being able to assume standardized travel to the school at which they are enrolled. The Centre gives them personal and individualized academic service at home to enable their development.
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentri…
2021
Control of dyslipidemia in chronic kidney disease (CKD) is not always guaranteed with statins and/or ezetimibe. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have opened up a new era in lipid control, but their effect on renal function and proteinuria in real life have not yet been evaluated. The aim of the present study was to analyze the evolution of renal function and proteinuria in a cohort of CKD patients treated with PCSK9i. This retrospective multicentric cohort study included CKD patients treated with PCSK9i. Baseline epidemiological data, comorbidities and laboratory findings (including estimated glomerular filtration rate [eGFR], proteinuria and lipid profile) …
Sodium-glucose cotransporter 2 inhibition : towards an indication to treat diabetic kidney disease
2020
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD. However, the indication of this drug class is still blood glucose lowering in type 2 diabetic patients with estimated glomerular filtration rate >45mL/min/1.73m2. Based on the new evidence, several scientific societies have emphasized the preferential prescription of SGLT2i for patients at risk of heart failure or kidney disease, but still within the limits set by health authorities. A r…